nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—NPY1R—nerve—chronic kidney failure	0.0365	0.109	CbGeAlD
Duloxetine—SLC6A2—sympathetic nervous system—chronic kidney failure	0.0328	0.0979	CbGeAlD
Duloxetine—HTR2A—arteriole—chronic kidney failure	0.0309	0.0924	CbGeAlD
Duloxetine—HTR2A—sympathetic nervous system—chronic kidney failure	0.0197	0.0589	CbGeAlD
Duloxetine—HTR2A—vein—chronic kidney failure	0.0184	0.0551	CbGeAlD
Duloxetine—SLC6A3—nerve—chronic kidney failure	0.0154	0.0459	CbGeAlD
Duloxetine—CYP1A2—urine—chronic kidney failure	0.0138	0.0412	CbGeAlD
Duloxetine—NPY1R—renal system—chronic kidney failure	0.0129	0.0387	CbGeAlD
Duloxetine—SLC6A2—nerve—chronic kidney failure	0.0124	0.037	CbGeAlD
Duloxetine—NPY1R—cortex of kidney—chronic kidney failure	0.0122	0.0364	CbGeAlD
Duloxetine—NPY1R—gonad—chronic kidney failure	0.0116	0.0347	CbGeAlD
Duloxetine—HTR2A—urine—chronic kidney failure	0.0108	0.0323	CbGeAlD
Duloxetine—SLC6A4—blood plasma—chronic kidney failure	0.0106	0.0318	CbGeAlD
Duloxetine—NPY1R—blood—chronic kidney failure	0.0101	0.0302	CbGeAlD
Duloxetine—CYP2D6—urine—chronic kidney failure	0.00983	0.0294	CbGeAlD
Duloxetine—HTR2A—artery—chronic kidney failure	0.00751	0.0224	CbGeAlD
Duloxetine—HTR2A—nerve—chronic kidney failure	0.00745	0.0223	CbGeAlD
Duloxetine—CYP1A2—blood plasma—chronic kidney failure	0.00721	0.0215	CbGeAlD
Duloxetine—HTR2A—blood plasma—chronic kidney failure	0.00563	0.0168	CbGeAlD
Duloxetine—CYP2D6—blood plasma—chronic kidney failure	0.00513	0.0153	CbGeAlD
Duloxetine—Propranolol—SLC22A2—chronic kidney failure	0.00475	0.169	CrCbGaD
Duloxetine—Fluoxetine—CYP2B6—chronic kidney failure	0.00425	0.151	CrCbGaD
Duloxetine—SLC6A4—digestive system—chronic kidney failure	0.00409	0.0122	CbGeAlD
Duloxetine—SLC6A2—gonad—chronic kidney failure	0.00394	0.0118	CbGeAlD
Duloxetine—SLC6A4—blood—chronic kidney failure	0.0039	0.0117	CbGeAlD
Duloxetine—CYP1A2—renal system—chronic kidney failure	0.00338	0.0101	CbGeAlD
Duloxetine—CYP1A2—digestive system—chronic kidney failure	0.00277	0.00828	CbGeAlD
Duloxetine—HTR2A—renal system—chronic kidney failure	0.00264	0.00789	CbGeAlD
Duloxetine—CYP1A2—blood—chronic kidney failure	0.00264	0.00789	CbGeAlD
Duloxetine—HTR2A—cardiovascular system—chronic kidney failure	0.00261	0.0078	CbGeAlD
Duloxetine—Fluoxetine—CYP2C19—chronic kidney failure	0.00257	0.0911	CrCbGaD
Duloxetine—Cinacalcet—CYP3A4—chronic kidney failure	0.00256	0.0907	CrCbGaD
Duloxetine—HTR2A—kidney—chronic kidney failure	0.00255	0.00763	CbGeAlD
Duloxetine—CYP2D6—renal system—chronic kidney failure	0.00241	0.00719	CbGeAlD
Duloxetine—HTR2A—gonad—chronic kidney failure	0.00237	0.00708	CbGeAlD
Duloxetine—CYP2D6—kidney—chronic kidney failure	0.00233	0.00695	CbGeAlD
Duloxetine—HTR2A—digestive system—chronic kidney failure	0.00217	0.00647	CbGeAlD
Duloxetine—HTR2A—blood—chronic kidney failure	0.00206	0.00617	CbGeAlD
Duloxetine—Protriptyline—ABCB1—chronic kidney failure	0.00199	0.0706	CrCbGaD
Duloxetine—CYP2D6—digestive system—chronic kidney failure	0.00197	0.0059	CbGeAlD
Duloxetine—CYP2D6—blood—chronic kidney failure	0.00188	0.00562	CbGeAlD
Duloxetine—Atomoxetine—CYP2C19—chronic kidney failure	0.00165	0.0585	CrCbGaD
Duloxetine—Fluoxetine—CYP3A4—chronic kidney failure	0.00163	0.0579	CrCbGaD
Duloxetine—Propranolol—CYP2C19—chronic kidney failure	0.00157	0.0556	CrCbGaD
Duloxetine—Propranolol—CYP1A1—chronic kidney failure	0.00156	0.0554	CrCbGaD
Duloxetine—Fluoxetine—ALB—chronic kidney failure	0.00142	0.0505	CrCbGaD
Duloxetine—Fluoxetine—ABCB1—chronic kidney failure	0.00136	0.0482	CrCbGaD
Duloxetine—Atomoxetine—CYP3A4—chronic kidney failure	0.00105	0.0372	CrCbGaD
Duloxetine—Propranolol—CYP3A4—chronic kidney failure	0.000996	0.0354	CrCbGaD
Duloxetine—Propranolol—ABCB1—chronic kidney failure	0.000829	0.0294	CrCbGaD
Duloxetine—HTR2A—Signaling Pathways—PIP5K1B—chronic kidney failure	0.000172	0.00027	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—NOS3—chronic kidney failure	0.000172	0.000269	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PRKAG2—chronic kidney failure	0.000169	0.000266	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—F2—chronic kidney failure	0.000168	0.000264	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—chronic kidney failure	0.000167	0.000262	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NPY—chronic kidney failure	0.000165	0.000259	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—NPS—chronic kidney failure	0.000164	0.000257	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—POMC—chronic kidney failure	0.000163	0.000256	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—RELA—chronic kidney failure	0.000162	0.000254	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—COL4A3—chronic kidney failure	0.000161	0.000252	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—DRD1—chronic kidney failure	0.00016	0.000252	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CRH—chronic kidney failure	0.000159	0.00025	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—OXT—chronic kidney failure	0.000159	0.00025	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ACAT1—chronic kidney failure	0.000157	0.000247	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCR5—chronic kidney failure	0.000157	0.000247	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HBEGF—chronic kidney failure	0.000157	0.000247	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PGF—chronic kidney failure	0.000156	0.000246	CbGpPWpGaD
Duloxetine—SLC6A2—Transmembrane transport of small molecules—ALB—chronic kidney failure	0.000154	0.000242	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—FABP1—chronic kidney failure	0.000154	0.000241	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CRHR1—chronic kidney failure	0.000153	0.00024	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—POMC—chronic kidney failure	0.000153	0.00024	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NCF1—chronic kidney failure	0.000153	0.00024	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL6—chronic kidney failure	0.000153	0.000239	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NPS—chronic kidney failure	0.000151	0.000237	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—AVP—chronic kidney failure	0.00015	0.000235	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CCL2—chronic kidney failure	0.00015	0.000235	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—F2—chronic kidney failure	0.000149	0.000233	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—DRD1—chronic kidney failure	0.000148	0.000233	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PRKAG2—chronic kidney failure	0.000147	0.000231	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—LRP2—chronic kidney failure	0.000147	0.000231	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—MLXIPL—chronic kidney failure	0.000146	0.00023	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	0.000146	0.00023	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GATM—chronic kidney failure	0.000146	0.000229	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—AGXT—chronic kidney failure	0.000146	0.000229	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—chronic kidney failure	0.000145	0.000228	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—IL6—chronic kidney failure	0.000145	0.000227	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CYBA—chronic kidney failure	0.000144	0.000225	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—EDN1—chronic kidney failure	0.000143	0.000224	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	0.000143	0.000224	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	0.000143	0.000224	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCL5—chronic kidney failure	0.000142	0.000222	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—PTH—chronic kidney failure	0.00014	0.00022	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—COL4A3—chronic kidney failure	0.000139	0.000219	CbGpPWpGaD
Duloxetine—SLC6A3—Transmembrane transport of small molecules—ALB—chronic kidney failure	0.000137	0.000215	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CYBB—chronic kidney failure	0.000137	0.000214	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HBEGF—chronic kidney failure	0.000136	0.000214	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—NFKB1—chronic kidney failure	0.000136	0.000214	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—AVP—chronic kidney failure	0.000136	0.000214	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	0.000136	0.000213	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—POMC—chronic kidney failure	0.000135	0.000212	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—F2—chronic kidney failure	0.000135	0.000212	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—SLC22A2—chronic kidney failure	0.000134	0.00021	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ACAT1—chronic kidney failure	0.000133	0.000209	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CRHR1—chronic kidney failure	0.000133	0.000209	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	0.000132	0.000207	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	0.00013	0.000205	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—AVP—chronic kidney failure	0.00013	0.000204	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—EDN1—chronic kidney failure	0.00013	0.000203	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—FGF23—chronic kidney failure	0.000129	0.000203	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL5—chronic kidney failure	0.000129	0.000202	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	0.000128	0.000201	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CCR5—chronic kidney failure	0.000128	0.0002	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—LRP2—chronic kidney failure	0.000128	0.0002	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HBEGF—chronic kidney failure	0.000126	0.000198	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ABCG1—chronic kidney failure	0.000124	0.000195	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	0.000124	0.000195	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—MLXIPL—chronic kidney failure	0.000124	0.000195	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—EDN1—chronic kidney failure	0.000124	0.000194	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—VEGFA—chronic kidney failure	0.000124	0.000194	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCL5—chronic kidney failure	0.000123	0.000193	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—POMC—chronic kidney failure	0.000123	0.000193	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PIP5K1B—chronic kidney failure	0.000122	0.000191	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NPY—chronic kidney failure	0.000122	0.000191	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	0.000122	0.000191	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—PTH—chronic kidney failure	0.000122	0.000191	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CCL2—chronic kidney failure	0.00012	0.000189	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ARG2—chronic kidney failure	0.000119	0.000187	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CYBB—chronic kidney failure	0.000119	0.000186	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—AVP—chronic kidney failure	0.000118	0.000186	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic kidney failure	0.000118	0.000185	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CRH—chronic kidney failure	0.000117	0.000184	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—OXT—chronic kidney failure	0.000117	0.000184	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—LCAT—chronic kidney failure	0.000117	0.000184	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCR5—chronic kidney failure	0.000116	0.000182	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—TGFB1—chronic kidney failure	0.000114	0.000178	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—SLC22A2—chronic kidney failure	0.000113	0.000178	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—EDN1—chronic kidney failure	0.000113	0.000177	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NCF1—chronic kidney failure	0.000112	0.000176	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—FGF23—chronic kidney failure	0.000112	0.000176	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL5—chronic kidney failure	0.000112	0.000175	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NPS—chronic kidney failure	0.000111	0.000175	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	0.000111	0.000174	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CCR5—chronic kidney failure	0.000111	0.000174	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—F2—chronic kidney failure	0.000109	0.000172	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—AVP—chronic kidney failure	0.000109	0.000172	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—DRD1—chronic kidney failure	0.000109	0.000171	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—DDC—chronic kidney failure	0.000107	0.000169	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CYBA—chronic kidney failure	0.000106	0.000166	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NPY—chronic kidney failure	0.000106	0.000166	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ABCG1—chronic kidney failure	0.000105	0.000165	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—KRAS—chronic kidney failure	0.000105	0.000165	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PRKD1—chronic kidney failure	0.000104	0.000164	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PRKAG2—chronic kidney failure	0.000104	0.000164	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CYP2B6—chronic kidney failure	0.000104	0.000164	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—EDN1—chronic kidney failure	0.000104	0.000163	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PIP5K1B—chronic kidney failure	0.000103	0.000162	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL5—chronic kidney failure	0.000103	0.000162	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CRH—chronic kidney failure	0.000102	0.00016	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—OXT—chronic kidney failure	0.000102	0.00016	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ARG2—chronic kidney failure	0.000101	0.000159	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—LPL—chronic kidney failure	0.000101	0.000158	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCR5—chronic kidney failure	0.000101	0.000158	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—POMC—chronic kidney failure	9.97e-05	0.000156	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—F2—chronic kidney failure	9.94e-05	0.000156	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—LCAT—chronic kidney failure	9.91e-05	0.000156	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—SREBF2—chronic kidney failure	9.76e-05	0.000153	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NCF1—chronic kidney failure	9.76e-05	0.000153	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NPS—chronic kidney failure	9.66e-05	0.000152	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NGF—chronic kidney failure	9.55e-05	0.00015	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—F2—chronic kidney failure	9.5e-05	0.000149	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—DRD1—chronic kidney failure	9.48e-05	0.000149	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—GCKR—chronic kidney failure	9.43e-05	0.000148	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ABCC3—chronic kidney failure	9.43e-05	0.000148	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCR5—chronic kidney failure	9.29e-05	0.000146	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HBEGF—chronic kidney failure	9.28e-05	0.000146	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—LPIN1—chronic kidney failure	9.23e-05	0.000145	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CYBA—chronic kidney failure	9.18e-05	0.000144	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—DDC—chronic kidney failure	9.1e-05	0.000143	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—POMC—chronic kidney failure	9.05e-05	0.000142	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CYP2C18—chronic kidney failure	9.04e-05	0.000142	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—LRP2—chronic kidney failure	9.04e-05	0.000142	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CCL2—chronic kidney failure	8.86e-05	0.000139	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CYP2B6—chronic kidney failure	8.83e-05	0.000139	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PRKD1—chronic kidney failure	8.83e-05	0.000139	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PRKAG2—chronic kidney failure	8.83e-05	0.000139	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	8.7e-05	0.000137	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—POMC—chronic kidney failure	8.66e-05	0.000136	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—F2—chronic kidney failure	8.63e-05	0.000135	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—IL6—chronic kidney failure	8.55e-05	0.000134	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	8.4e-05	0.000132	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—SREBF2—chronic kidney failure	8.27e-05	0.00013	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HBEGF—chronic kidney failure	8.06e-05	0.000126	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—AVP—chronic kidney failure	8.05e-05	0.000126	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—GCKR—chronic kidney failure	7.99e-05	0.000125	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ABCC3—chronic kidney failure	7.99e-05	0.000125	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—F2—chronic kidney failure	7.97e-05	0.000125	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—POMC—chronic kidney failure	7.86e-05	0.000123	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—LPIN1—chronic kidney failure	7.82e-05	0.000123	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CCL2—chronic kidney failure	7.69e-05	0.000121	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CPT1A—chronic kidney failure	7.69e-05	0.000121	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	7.68e-05	0.000121	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—LRP2—chronic kidney failure	7.66e-05	0.00012	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CYP2C18—chronic kidney failure	7.66e-05	0.00012	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—EDN1—chronic kidney failure	7.65e-05	0.00012	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL5—chronic kidney failure	7.59e-05	0.000119	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IRS1—chronic kidney failure	7.54e-05	0.000118	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CYP2C19—chronic kidney failure	7.49e-05	0.000118	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—LIPC—chronic kidney failure	7.49e-05	0.000118	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—LPL—chronic kidney failure	7.43e-05	0.000117	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—POMC—chronic kidney failure	7.26e-05	0.000114	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CCL2—chronic kidney failure	7.1e-05	0.000112	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NGF—chronic kidney failure	7.03e-05	0.00011	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—AVP—chronic kidney failure	6.99e-05	0.00011	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IGF1—chronic kidney failure	6.98e-05	0.00011	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—SCARB1—chronic kidney failure	6.92e-05	0.000109	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PTGS1—chronic kidney failure	6.85e-05	0.000108	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCR5—chronic kidney failure	6.84e-05	0.000107	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—SREBF1—chronic kidney failure	6.72e-05	0.000105	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—EDN1—chronic kidney failure	6.65e-05	0.000104	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—SERPINE1—chronic kidney failure	6.63e-05	0.000104	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL5—chronic kidney failure	6.59e-05	0.000104	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—KRAS—chronic kidney failure	6.57e-05	0.000103	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—HMGCR—chronic kidney failure	6.54e-05	0.000103	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CPT1A—chronic kidney failure	6.51e-05	0.000102	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—LPL—chronic kidney failure	6.45e-05	0.000101	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—FASN—chronic kidney failure	6.4e-05	0.0001	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—LIPC—chronic kidney failure	6.35e-05	9.96e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CYP2C19—chronic kidney failure	6.35e-05	9.96e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NOS3—chronic kidney failure	6.33e-05	9.94e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	6.26e-05	9.83e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NGF—chronic kidney failure	6.11e-05	9.59e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—RELA—chronic kidney failure	5.96e-05	9.36e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCR5—chronic kidney failure	5.94e-05	9.33e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CYP3A4—chronic kidney failure	5.93e-05	9.3e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—F2—chronic kidney failure	5.87e-05	9.21e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—SCARB1—chronic kidney failure	5.86e-05	9.2e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ABCA1—chronic kidney failure	5.83e-05	9.15e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PTGS1—chronic kidney failure	5.8e-05	9.11e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	5.71e-05	8.96e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—SREBF1—chronic kidney failure	5.69e-05	8.94e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IRS1—chronic kidney failure	5.55e-05	8.72e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—HMGCR—chronic kidney failure	5.54e-05	8.69e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—FASN—chronic kidney failure	5.42e-05	8.51e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—POMC—chronic kidney failure	5.35e-05	8.39e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—IL6—chronic kidney failure	5.34e-05	8.38e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CCL2—chronic kidney failure	5.23e-05	8.21e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IGF1—chronic kidney failure	5.14e-05	8.07e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—F2—chronic kidney failure	5.1e-05	8e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—NFKB1—chronic kidney failure	5.03e-05	7.89e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CYP3A4—chronic kidney failure	5.02e-05	7.88e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	4.99e-05	7.84e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ABCA1—chronic kidney failure	4.94e-05	7.75e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CAT—chronic kidney failure	4.93e-05	7.74e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—SERPINE1—chronic kidney failure	4.88e-05	7.67e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—KRAS—chronic kidney failure	4.83e-05	7.59e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IRS1—chronic kidney failure	4.82e-05	7.57e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ABCB1—chronic kidney failure	4.8e-05	7.53e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NOS3—chronic kidney failure	4.66e-05	7.32e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—POMC—chronic kidney failure	4.64e-05	7.29e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—LPL—chronic kidney failure	4.57e-05	7.18e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—VEGFA—chronic kidney failure	4.56e-05	7.16e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CCL2—chronic kidney failure	4.54e-05	7.13e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IGF1—chronic kidney failure	4.47e-05	7.01e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CYP1A1—chronic kidney failure	4.42e-05	6.93e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—RELA—chronic kidney failure	4.39e-05	6.89e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—SERPINE1—chronic kidney failure	4.24e-05	6.66e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—KRAS—chronic kidney failure	4.2e-05	6.59e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—TGFB1—chronic kidney failure	4.19e-05	6.57e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CAT—chronic kidney failure	4.18e-05	6.56e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—MTHFR—chronic kidney failure	4.12e-05	6.46e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ABCB1—chronic kidney failure	4.06e-05	6.38e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NOS3—chronic kidney failure	4.05e-05	6.36e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PPARA—chronic kidney failure	4.04e-05	6.34e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—IL6—chronic kidney failure	3.93e-05	6.17e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—KRAS—chronic kidney failure	3.88e-05	6.09e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—LPL—chronic kidney failure	3.87e-05	6.08e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—RELA—chronic kidney failure	3.81e-05	5.98e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CYP1A1—chronic kidney failure	3.74e-05	5.87e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—NFKB1—chronic kidney failure	3.7e-05	5.81e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—MTHFR—chronic kidney failure	3.49e-05	5.47e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PPARA—chronic kidney failure	3.42e-05	5.37e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—IL6—chronic kidney failure	3.42e-05	5.36e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—VEGFA—chronic kidney failure	3.36e-05	5.27e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—POMC—chronic kidney failure	3.29e-05	5.17e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—NFKB1—chronic kidney failure	3.21e-05	5.05e-05	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—IL6—chronic kidney failure	3.16e-05	4.95e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—TGFB1—chronic kidney failure	3.08e-05	4.84e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—ALB—chronic kidney failure	3e-05	4.71e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—VEGFA—chronic kidney failure	2.92e-05	4.58e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—NOS3—chronic kidney failure	2.87e-05	4.51e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—KRAS—chronic kidney failure	2.86e-05	4.48e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—POMC—chronic kidney failure	2.79e-05	4.38e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—TGFB1—chronic kidney failure	2.68e-05	4.2e-05	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—PTGS2—chronic kidney failure	2.63e-05	4.12e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—ALB—chronic kidney failure	2.54e-05	3.99e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—KRAS—chronic kidney failure	2.48e-05	3.89e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—NOS3—chronic kidney failure	2.43e-05	3.82e-05	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—IL6—chronic kidney failure	2.32e-05	3.65e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—PTGS2—chronic kidney failure	2.22e-05	3.49e-05	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—IL6—chronic kidney failure	2.02e-05	3.17e-05	CbGpPWpGaD
